Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

I don't think most people are nostalgic for this a

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72447
(Total Views: 311)
Posted On: 07/17/2017 9:14:45 PM
Avatar
Posted By: Phteven C
Re: sox0407 #35983
I don't think most people are nostalgic for this article. I'd call it a comedy of bad predictions if it wasn't so tragic.

Look at some of the gems from that article:

Quote:
may actually leave me owing Pharmasset a debt of gratitude as it is theoretically possible that Cellceutix will leapfrog past Pharmasset’s lead compound in the overall FDA approval process in the next 18 months.



This was in May 2011 folks. Pharmasset was bought out six months later for $11 billion. I'm sure this author is thrilled he put dollars into CTIX instead of VRUS. I'm sure some of the folks on this board are too.

Quote:
Even though KevetrinTM is addressing a much larger target population and potential revenue would far exceed a $3.75 billion market cap (market cap is typically valued at 4 to 5 times potential sales), a valuation comparable to Phamasset’s market cap would place the cost of a share of Cellceutix around $42.



It was a piece that name dropped VRUS at the height of it's results frenzy. The CTIX stock price was around $0.90 in 2011 when this was written - similar prices to what we're offered today in 2017. When you consider that he NASDAQ index has more than doubled since this article was published it hurts even more. This article hit anyone who invested in CTIX at the time with quite the opportunity cost.

Quote:
The “Accelerated Approval” and “Priority Review” programs are exactly what Cellceutix will be focused upon should efficacy should be demonstrated which could literally mean a jump straight to Phase III clinical trials after a very minimal time in Phase I..



This author dangled a fast track "jump staight into phase 3" after a "very minimal" time in phase 1. In reality it took almost six years from the publishing of this article to initiate our first Phase 2A for Kevetrin. Talk about getting your timing wrong.

It's also instructive that your favorite article on Kevetrin to date was published over six years ago prior to IND. You've probably done more digging on this company and the ecosystem than most. That you haven't found a new favorite since then speaks volumes as to why there is little market excitement surrounding Kevetrin at this time.

Of all the exciting things we have brewing you dusted this article off? It's a nice overview of Kevetrin but some of these predictions were worse than 80's fashion.

Go IPIX!


(2)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us